Laparoscopy in the staging of pancreatic cancer

British Journal of Surgery

Volumn 88, Issue 3, 2001, Pages 325-337

  Pisters, P W T ^a   Lee, J E ^a   Vauthey, J N ^a   Charnsangavej, C ^a   Evans, D B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; IMAGE QUALITY; INTERMETHOD COMPARISON; LAPAROSCOPY; MESENTERY BLOOD FLOW; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

COST-BENEFIT ANALYSIS; HUMANS; LAPAROSCOPY; MALE; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035074569     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2001.01695.x     Document Type: Review

References (45)

1. Laparoscopy for pancreatic cancer: Does it benefit the patient?
2. Value of laparoscopy in the diagnosis and management of pancreatic carcinoma
3. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy
4. Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer
5. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
6. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma
7. Diagnostic workup of patients with suspected pancreatic carcinoma: The University of California-Los Angeles approach
8. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies
9. Impact of laparoscopic staging in the treatment of pancreatic cancer
10. Standards for pancreatic resection in the 1990s
11. The role of laparoscopy in the management of suspected pancreatic and periampullary malignancies
12. The role of laparoscopy in the preoperative staging of pancreatic carcinoma
13. Controversies in clinical pancreatology. Workup of a patient with a mass in the head of the pancreas
14. Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?
15. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms
16. Cancer of the pancreas
17. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography
18. Staging laparoscopy and laparoscopic ultrasonography in more than 400 patients with upper gastrointestinal carcinoma
19. Computed tomography and laparoscopy in the assessment of the patient with pancreatic cancer
20. The role of laparoscopy and ultrafast magnetic resonance imaging in the preoperative staging of pancreatic carcinoma
21. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head
22. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication to resection?
23. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head
24. Carcinoma of the periampullary region: Who benefits from portal vein resection?
25. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer
26. Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis
27. Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region
28. Staging laparoscopy with laparoscopic ultrasonography: Optimizing resectability in hepatobiliary and pancreatic malignancy
29. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality
30. Survival in 1001 patients with carcinoma of the pancreas
31. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer
32. Pancreatic carcinoma
33. Staging laparoscopy for pancreatic cancer should be used to select the best means of palliation and not only to maximize the resectability rate
34. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma
35. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
36. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+ 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group
37. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience
38. Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy
39. Adjuvant therapy of resected adenocarcinoma of the pancreas
40. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy
41. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
42. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients
43. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?
44. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas: Treatment variables and survival duration
45. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer